根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-20-021716 Act: 34 Size: 287 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-20-021493 Act: 34 Size: 375 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-021361 Act: 33 Size: 412 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-021287 Act: 33 Size: 414 KB 网页链接
$Isoray(ISR)$ 8-K Current report, item 1.02 Accession Number: 0001437749-20-021279 Act: 34 Size: 19 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-20-021255 Act: 34 Size: 38 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-020439 Act: 33 Size: 1 MB 网页链接
$Isoray(ISR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-20-020189 Act: 34 Size: 4 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-20-019834 Act: 34 Size: 202 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-20-019034 Act: 34 Size: 88 KB 网页链接